Abstract
We report 3 cases of allogeneic bone marrow transplantation in multiple myeloma that we have recently performed. Following conditioning treatment with i.v. cyclophosphamide (60 mg/kg/d, for 2 d), oral melphalan (1.0 mg/kg/d, for 5 d), i.v. BCNU (5.5 mg/kg, in a single dose) and total body irradiation (10 Gy in a single fraction) we observed in all 3 cases the disappearance both of serum M component and of monoclonal bone marrow plasma cells. 1 patient died of actue GVH disease, grade IV, at 2 months, while the other 2 patients are in good health and in unmaintained complete remission at 4 and 20 months, respectively. The usefulness of allogeneic bone marrow transplantation in the management of multiple myeloma is emphasized.
| Original language | English |
|---|---|
| Pages (from-to) | 176-179 |
| Number of pages | 4 |
| Journal | Scandinavian Journal of Haematology |
| Volume | 36 |
| Issue number | 2 |
| Publication status | Published - 1986 |
ASJC Scopus subject areas
- Hematology
Fingerprint Dive into the research topics of 'Bone marrow transplantation in multiple myeloma'. Together they form a unique fingerprint.
Cite this
Tura, S., Cavo, M., Baccarani, M., Ricci, P., & Gobbi, M. (1986). Bone marrow transplantation in multiple myeloma. Scandinavian Journal of Haematology, 36(2), 176-179.